You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 244 No. 12, September 19, 1980 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (99)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethinyl Estradiol and Conjugated Estrogens as Postcoital Contraceptives

Garrett W. Dixon, MD; James J. Schlesselman, PhD; Howard W. Ory, MD; Richard P. Blye, PhD

JAMA. 1980;244(12):1336-1339.


Abstract

Five study centers enrolled 1,311 women seeking postcoital contraception methods. Ethinyl estradiol was administered at 5 mg/day and conjugated estrogens at 30 mg/day for five consecutive days starting within 72 hours of unprotected coitus. Eleven pregnancies occurred in the 976 women who had a single unprotected coitus at midcycle. Based on published information, 69 pregnancies would have been expected if no contraceptives were used. Although both treatments were effective in preventing pregnancy, ethinyl estradiol seemed to be more effective. At the two centers alternately prescribing both drugs, none of 137 women treated with ethinyl estradiol became pregnant, while six of the 132 given conjugated estrogens became pregnant. Women whose treatment commenced on the first postcoital day seemed to have lower pregnancy rates than those whose medication was delayed to the second or third postcoital day regardless of which drug was used. Side effects were mainly limited to nausea that occurred in 70% and vomiting that was experienced by 33% of all women treated.

(JAMA 244:1336-1339, 1980)



Author Affiliations

From the Family Planning Evaluation Division, Bureau of Epidemiology, Center for Disease Control, Atlanta (Drs Dixon and Ory), and the National Institute of Child Health and Human Development, Bethesda, Md (Drs Schlesselman and Blye).


Footnotes

Reprint requests to Center for Disease Control, Epidemiologic Studies Branch, Family Planning Evaluation Division, Bureau of Epidemiology, Atlanta, GA 30333 (Dr Ory).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A national study examining the effect of making emergency hormonal contraception available without prescription
Killick and Irving
Hum Reprod 2004;19:553-557.
ABSTRACT | FULL TEXT  

Emergency Contraception
Grimes and Raymond
ANN INTERN MED 2002;137:180-189.
ABSTRACT | FULL TEXT  

Emergency Postcoital Contraception
Glasier
NEJM 1997;337:1058-1064.
FULL TEXT  

Reversible Contraception for the 1980s
Grimes
JAMA 1986;255:69-75.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.